Interpace Biosciences, Inc. SEC filings IDXG

Interpace Biosciences, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Nov 6, 2003. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (results of operations). The company's fiscal year ends on December 31.

Interpace Biosciences, Inc. SEC filings
Form Description Filed Period
8-A12B Filing Nov 5, 2026 —
S-1/A Amended registration statement Oct 30, 2026 —
FWP Free writing prospectus Oct 15, 2026 —
8-K Current report
Results of operations
Oct 15, 2026 Oct 14, 2026
S-1/A Amended registration statement Oct 1, 2026 —
S-1 Registration statement Sep 25, 2026 —
S-8 Employee stock plan registration Sep 17, 2026 —
8-K Current report
Bylaw or fiscal year change, Regulation FD disclosure
Aug 27, 2026 Aug 27, 2026
8-K/A Amended current report
Officer or director change
Aug 26, 2026 Aug 20, 2026
8-K Current report
Shareholder vote results
Aug 21, 2026 Aug 20, 2026
4 Insider transaction Aug 20, 2026 Aug 20, 2026
4 Insider transaction Aug 20, 2026 Aug 20, 2026
4 Insider transaction Aug 20, 2026 Aug 20, 2026
4 Insider transaction Aug 20, 2026 Aug 20, 2026
4 Insider transaction Aug 20, 2026 Aug 20, 2026
4 Insider transaction Aug 20, 2026 Aug 20, 2026
8-K Current report
Results of operations
Aug 12, 2026 Aug 10, 2026
10-Q Quarterly report Aug 10, 2026 Jun 30, 2026
DRS Filing Jul 22, 2026 —
DEFA14A Additional proxy material Jul 7, 2026 —
DEF 14A Proxy statement Jul 7, 2026 Jul 7, 2026
PREM14A Filing Jun 25, 2026 Jun 24, 2026
PRE 14A Preliminary proxy statement Jun 23, 2026 Jun 23, 2026
8-K Current report
Results of operations
May 14, 2026 May 12, 2026
10-Q Quarterly report May 12, 2026 Mar 31, 2026
10-K/A Amended annual report Apr 30, 2026 Dec 31, 2025
8-K Current report
Results of operations
Apr 1, 2026 Mar 30, 2026
10-K Annual report Mar 30, 2026 Dec 31, 2025
4 Insider transaction Feb 17, 2026 Jan 20, 2026
4 Insider transaction Feb 4, 2026 Jan 20, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Jan 20, 2026 Jan 20, 2026
8-K Current report
Other events
Dec 3, 2025 Dec 3, 2025
8-K Current report
Results of operations
Nov 12, 2025 Nov 12, 2025
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
8-K Current report
Results of operations
Aug 8, 2025 Aug 7, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
8-K Current report
Exit or restructuring costs, Other events
May 1, 2025 Apr 25, 2025
10-K/A Amended annual report Apr 28, 2025 Dec 31, 2024
4 Insider transaction Apr 25, 2025 Jul 31, 2023
10-K Annual report Mar 31, 2025 Dec 31, 2024
8-K Current report
Restatement
Mar 6, 2025 Feb 28, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
8-K Current report
Exit or restructuring costs, Other events
Jan 27, 2025 Jan 27, 2025
8-K Current report
Material agreement, New debt, Exit or restructuring costs
Jan 21, 2025 Jan 14, 2025
8-K Current report
Other events
Jan 10, 2025 Jan 9, 2025
8-K Current report
Shareholder vote results
Nov 13, 2024 Nov 12, 2024
10-Q Quarterly report Nov 8, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 6, 2024 Nov 4, 2024
SC 13D/A Amended ownership over 5% (active) Oct 16, 2024 —
SC 13D/A Amended ownership over 5% (active) Oct 16, 2024 —
D Filing Oct 16, 2024 —
4 Insider transaction Oct 15, 2024 Oct 11, 2024
4 Insider transaction Oct 15, 2024 Oct 11, 2024
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Oct 15, 2024 Oct 10, 2024
DEFA14A Additional proxy material Sep 20, 2024 —
DEF 14A Proxy statement Sep 20, 2024 Sep 20, 2024
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 2, 2024 Aug 1, 2024
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
10-Q Quarterly report May 9, 2024 Mar 31, 2024
10-K/A Amended annual report Apr 26, 2024 Dec 31, 2023
10-K Annual report Apr 1, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 13, 2024 Mar 7, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 12, 2024 —
4 Insider transaction Feb 6, 2024 Feb 1, 2024
8-K Current report
Officer or director change
Dec 12, 2023 Dec 7, 2023
8-K Current report
Officer or director change, Shareholder vote results
Nov 16, 2023 Nov 14, 2023
8-K Current report
Results of operations
Nov 8, 2023 Nov 8, 2023
10-Q Quarterly report Nov 8, 2023 Sep 30, 2023
8-K Current report
Material agreement, New debt
Oct 27, 2023 Oct 24, 2023
DEFA14A Additional proxy material Sep 22, 2023 —
DEF 14A Proxy statement Sep 22, 2023 Sep 22, 2023
8-K Current report
Results of operations
Aug 9, 2023 Aug 9, 2023
10-Q Quarterly report Aug 9, 2023 Jun 30, 2023
8-K Current report
Officer or director change
Aug 2, 2023 Jul 31, 2023
4 Insider transaction Aug 1, 2023 Jul 31, 2023
8-K Current report
Results of operations
May 12, 2023 May 12, 2023
10-Q Quarterly report May 12, 2023 Mar 31, 2023
3 Initial insider ownership May 3, 2023 Apr 21, 2023
10-K/A Amended annual report Apr 28, 2023 Dec 31, 2022
8-K Current report
Officer or director change
Apr 25, 2023 Apr 21, 2023
8-K Current report
Results of operations
Mar 27, 2023 Mar 27, 2023
10-K Annual report Mar 27, 2023 Dec 31, 2022
SC 13G/A Amended ownership over 5% (passive) Feb 10, 2023 —
8-K Current report
Officer or director change, Shareholder vote results
Nov 15, 2022 Nov 10, 2022
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 14, 2022 Nov 14, 2022
8-K Current report
Material agreement, New debt
Nov 4, 2022 Oct 31, 2022
8-K Current report
Officer or director change
Oct 4, 2022 Sep 30, 2022
DEFA14A Additional proxy material Sep 20, 2022 —
DEF 14A Proxy statement Sep 20, 2022 Sep 20, 2022
PRE 14A Preliminary proxy statement Sep 9, 2022 Sep 9, 2022
8-K Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure
Sep 7, 2022 Aug 31, 2022
8-K Current report
Results of operations
Aug 15, 2022 Aug 15, 2022
10-Q Quarterly report Aug 15, 2022 Jun 30, 2022
RW Filing Jun 16, 2022 —
10-Q Quarterly report May 16, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 16, 2022 May 16, 2022
8-K Current report
Material agreement, New debt
May 10, 2022 May 5, 2022
10-K/A Amended annual report May 2, 2022 Dec 31, 2021
8-K Current report
Auditor change
Apr 14, 2022 Apr 13, 2022
8-K Current report
Results of operations
Mar 31, 2022 Mar 31, 2022
10-K Annual report Mar 31, 2022 Dec 31, 2021
SC 13G Ownership over 5% (passive) Feb 10, 2022 —
4 Insider transaction Feb 2, 2022 Feb 1, 2022
3 Initial insider ownership Feb 2, 2022 Feb 1, 2022
SC 13D/A Amended ownership over 5% (active) Feb 1, 2022 —
8-K Current report
Agreement ended, Other events
Jan 31, 2022 Jan 28, 2022
8-K Current report
Material agreement, Officer or director change, Regulation FD disclosure
Jan 27, 2022 Jan 21, 2022
SC 13D/A Amended ownership over 5% (active) Jan 13, 2022 —
424B4 Prospectus Jan 13, 2022 —
POS EX Filing Jan 13, 2022 —
EFFECT Filing Jan 12, 2022 —
CORRESP Letter to the SEC Jan 10, 2022 —
S-1/A Amended registration statement Jan 7, 2022 —
S-1/A Amended registration statement Jan 3, 2022 —
UPLOAD Letter from the SEC Dec 10, 2021 —
SC 13D/A Amended ownership over 5% (active) Dec 6, 2021 —
S-1 Registration statement Dec 6, 2021 —
SC 13D/A Amended ownership over 5% (active) Nov 12, 2021 —
SC 13D/A Amended ownership over 5% (active) Nov 12, 2021 —
10-Q Quarterly report Nov 10, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 10, 2021 Nov 10, 2021
8-K Current report
Shareholder vote results
Nov 10, 2021 Nov 8, 2021
8-K Current report
Material agreement, New debt, Other events
Nov 3, 2021 Oct 29, 2021
8-K Current report
Material agreement, New debt, Other events
Oct 19, 2021 Oct 13, 2021
8-K Current report
Material agreement, New debt
Oct 1, 2021 Sep 29, 2021
DEF 14A Proxy statement Sep 27, 2021 Sep 27, 2021
8-K Current report
Material agreement, New debt
Aug 31, 2021 Aug 31, 2021
UPLOAD Letter from the SEC Aug 27, 2021 —
CORRESP Letter to the SEC Aug 20, 2021 —
10-K/A Amended annual report Aug 20, 2021 Dec 31, 2020
10-K/A Amended annual report Aug 20, 2021 Dec 31, 2019
UPLOAD Letter from the SEC Aug 11, 2021 —
10-Q Quarterly report Aug 11, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 10, 2021 Aug 10, 2021
8-K Current report Aug 6, 2021 Aug 6, 2021
8-K Current report
Material agreement, New debt
Jun 29, 2021 Jun 24, 2021
4 Insider transaction May 25, 2021 May 21, 2021
SC 13D/A Amended ownership over 5% (active) May 20, 2021 —
SC 13D/A Amended ownership over 5% (active) May 18, 2021 —
8-K Current report
Results of operations
May 11, 2021 May 11, 2021
10-Q Quarterly report May 11, 2021 Mar 31, 2021
10-K/A Amended annual report Apr 29, 2021 Dec 31, 2020
25-NSE Delisting notice Apr 26, 2021 —
8-K Current report
Results of operations
Apr 5, 2021 Mar 31, 2021
10-K Annual report Apr 1, 2021 Dec 31, 2020
NT 10-K Filing Apr 1, 2021 Dec 31, 2020
4 Insider transaction Mar 12, 2021 Mar 10, 2021
4 Insider transaction Mar 1, 2021 Feb 26, 2021
3 Initial insider ownership Mar 1, 2021 Feb 18, 2021
SC 13D Ownership over 5% (active) Mar 1, 2021 —
8-K Current report
Listing notice, Other events
Feb 25, 2021 Feb 24, 2021
8-K Current report
Listing notice, Regulation FD disclosure, Other events
Feb 17, 2021 Feb 16, 2021
SC 13G/A Amended ownership over 5% (passive) Feb 12, 2021 —
8-K Current report
Officer or director change, Regulation FD disclosure
Feb 4, 2021 Jan 31, 2021
4 Insider transaction Feb 2, 2021 Jan 29, 2021
S-8 Employee stock plan registration Jan 29, 2021 —
SC 13D/A Amended ownership over 5% (active) Jan 21, 2021 —
8-K Current report
Results of operations
Jan 20, 2021 Jan 20, 2021
10-Q Quarterly report Jan 20, 2021 Sep 30, 2020
10-Q/A Amended quarterly report Jan 19, 2021 Jun 30, 2020
10-Q/A Amended quarterly report Jan 19, 2021 Mar 31, 2020
10-K/A Amended annual report Jan 19, 2021 Dec 31, 2019
SC 13D/A Amended ownership over 5% (active) Jan 19, 2021 —
8-K Current report
Material agreement, Agreement ended, New debt
Jan 11, 2021 Jan 5, 2021
8-K Current report
Impairment, Restatement
Dec 8, 2020 Dec 7, 2020
4 Insider transaction Dec 2, 2020 Dec 1, 2020
4 Insider transaction Dec 2, 2020 Dec 1, 2020
3 Initial insider ownership Dec 2, 2020 Dec 1, 2020
8-K Current report
Officer or director change, Regulation FD disclosure
Nov 25, 2020 Nov 23, 2020
8-K Current report
Listing notice, Regulation FD disclosure
Nov 19, 2020 Nov 18, 2020
NT 10-Q Filing Nov 17, 2020 Sep 30, 2020
8-K Current report
Material agreement, New debt, Listing notice, Other events
Oct 23, 2020 Oct 19, 2020
8-K Current report
Results of operations
Oct 20, 2020 Oct 20, 2020
10-Q Quarterly report Oct 19, 2020 Jun 30, 2020
8-K Current report
Other events
Oct 14, 2020 Oct 14, 2020
SC 13G Ownership over 5% (passive) Sep 11, 2020 —
SC 13D/A Amended ownership over 5% (active) Aug 20, 2020 —
8-K Current report
Listing notice, Regulation FD disclosure
Aug 20, 2020 Aug 18, 2020
NT 10-Q Filing Aug 14, 2020 Jun 30, 2020
8-K Current report
Other events
Aug 14, 2020 Aug 14, 2020
4 Insider transaction Jul 31, 2020 Jul 29, 2020
SC 13D Ownership over 5% (active) Jul 24, 2020 —
8-K Current report
Officer or director change, Shareholder vote results
Jul 14, 2020 Jul 9, 2020
4 Insider transaction Jul 13, 2020 Jul 9, 2020
4 Insider transaction Jul 10, 2020 Jul 9, 2020
4 Insider transaction Jul 10, 2020 Jul 9, 2020
4 Insider transaction Jul 10, 2020 Jul 9, 2020
10-Q Quarterly report Jun 26, 2020 Mar 31, 2020
8-K Current report
Results of operations
Jun 25, 2020 Jun 25, 2020
DEF 14A Proxy statement Jun 10, 2020 Jun 9, 2020
8-K Current report
Material agreement, New debt
Jun 9, 2020 Jun 3, 2020
10-K/A Amended annual report May 29, 2020 Dec 31, 2019
PRE 14A Preliminary proxy statement May 20, 2020 May 19, 2020
8-K Current report
Other events
May 15, 2020 May 15, 2020
8-K Current report
Officer or director change
May 5, 2020 Apr 29, 2020

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
IDXG (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Parsippany, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1054102
Former names
Interpace Diagnostics Group, Inc. (until Nov 1, 2019); PDI INC (until Dec 22, 2015); PROFESSIONAL DETAILING INC (until Nov 13, 2002)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.